South Africa paused its use of the AstraZeneca COVID-19 vaccine after early results showed the jab was less effective against the Beta variant.
AstraZeneca kicks off human trials for new vaccine targeting COVID-19 variant
South Africa paused its use of the AstraZeneca COVID-19 vaccine after early results showed the jab was less effective against the Beta variant.